Long-term outcomes after Fontan vary widely. Although pre-Fontan hemodynamics predict early failure, their association with long-term outcomes remains unclear. We hypothesized that pre-Fontan hemodynamics predict long-term risk of death or transplantation.

Tricuspid regurgitation (TR) leads to systemic venous congestion and congestive hepatopathy, but conventional TR imaging parameters incompletely capture systemic consequences. Hepatic extracellular volume fraction (ECV) on cardiac magnetic resonance T1 mapping may reflect hepatic tissue remodeling and provide prognostic information beyond conventional risk markers.

Computed tomography based planimetric assessment of the anatomic aortic valve area (aAVACTA) in aortic stenosis is routinely performed. Unlike transthoracic echocardiography (TTE)-based effective AVA by TTE, it lacks clearly defined severity cutoff values, limiting clinical utility.

Polycystic ovarian syndrome (PCOS) is associated with increased cardiovascular morbidity and a higher risk of atherosclerotic cardiovascular disease. PCOS has been associated with electrocardiographic alterations. However, the potential long-term risk of cardiac arrhythmias in women with PCOS remains insufficiently investigated.

Atrial secondary mitral regurgitation (aSMR) is a distinct subtype of SMR characterized by normal leaflets, annular dilatation, left atrial (LA) enlargement, and preserved left ventricular function. Treatment pathways for aSMR are undefined, and limited data exist regarding outcomes following mitral transcatheter edge-to-edge repair (MTEER). The analysis aimed to evaluate outcomes in patients with aSMR treated with MTEER from the EXPANDed (Evaluation of the MitraClip X System Post-MArket Real-World CliNical Outcomes Database ) studies.

Heart failure with preserved ejection fraction (HFpEF) is a multifaceted syndrome that often presents diagnostic challenges due to its diverse causes and overlapping symptoms with other conditions. Its prevalence is increasing, driven by an aging population and rising associated comorbidities including obesity, diabetes, and hypertension. Echocardiography is a cornerstone in the screening and diagnosis of HFpEF due to its noninvasive nature, accessibility, and ability to provide a comprehensive cardiac assessment. Cardiac magnetic resonance can further enhance diagnostic accuracy and be a useful tool in follow-up. Cardiac magnetic resonance tissue characterization by parametric mapping sequences (T1/T2 mapping, late gadolinium enhancement, extracellular volume quantification, myocardial flow reserve, and myocardial strain) is also helpful in evaluating specific conditions that can lead to symptoms of heart failure in the setting of normal ejection fraction. The role of cardiac magnetic resonance has become increasingly important with the emergence of new therapies, as distinguishing HFpEF causes is essential for precise therapy selection. In this review, we describe the diagnostic imaging features associated with HFpEF, along with the potential role of imaging in follow-up. We also propose a diagnostic workflow for suspected HFpEF cases in clinical practice.

The American Heart Association annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and cardiovascular-kidney-metabolic syndrome) that contribute to cardiovascular health. The 2026 Heart Disease and Stroke Statistics Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).

Transcatheter edge-to-edge repair is an established treatment for tricuspid regurgitation (TR) in nonoptimal surgical candidates. Two techniques have been described: zipping (or bicuspidization) and clover (or triple-orifice). This study aimed to compare the echocardiographic and clinical outcomes of these 2 techniques.